The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Malignant phaeochromocytomas are rare tumours accounting for ~10% of all phaeochromocytomas; the prevalence of malignancy among paragangliomas is higher, especially those associated with succinate dehydrogenase subunit B gene mutations. Although a subset of these tumours has metastatic disease at in...
Main Authors: | Chrisoulidou, A, Kaltsas, G, Ilias, I, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
by: Kaltsas, G, et al.
Published: (2004) -
The clinical genetics of phaeochromocytoma and paraganglioma
by: P. T. Kavinga Gunawardane, et al. -
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
by: Bomanji, J, et al.
Published: (1993) -
Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
by: Bouloux, P, et al.
Published: (1986) -
Precision Medicine in Phaeochromocytoma and Paraganglioma
by: Bettina Winzeler, et al.
Published: (2021-11-01)